Cargando…
HER2-positive double primary tumor of gastric and breast cancer occur synchronously in a patient: A case report
The simultaneous occurrence of primary gastric cancer and breast cancer is rare, and the positive expression of human epidermal growth factor receptor (HER)2 in double primary carcinoma of gastric and breast cancer remains to be reported. The present study presented a 46-year-old woman complaining o...
Autores principales: | OUYANG, QUCHANG, TIAN, CAN, GAO, JIANXIANG, HUANG, JIN, FU, HUA, HE, JINSONG, YANG, JIANBO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840576/ https://www.ncbi.nlm.nih.gov/pubmed/27123269 http://dx.doi.org/10.3892/mco.2016.812 |
Ejemplares similares
-
Complete response to pyrotinib combined with letrozole as first-line treatment of HER2-positive/HR-positive breast cancer: a case report
por: Xie, Ning, et al.
Publicado: (2021) -
Molecular landscape of
TP53
mutations in breast cancer and their utility for predicting the response to HER‐targeted therapy in HER2 amplification‐positive and HER2 mutation‐positive amplification‐negative patients
por: Liu, Binliang, et al.
Publicado: (2022) -
The prognosis and risk factors for capecitabine maintenance treatment in metastatic breast cancer: a retrospective comparative cohort study
por: Tian, Can, et al.
Publicado: (2022) -
Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study
por: Li, Junjie, et al.
Publicado: (2018) -
Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes
por: Kochi, Mitsugu, et al.
Publicado: (2013)